Literature DB >> 21955126

Late-night salivary cortisol for diagnosis of Cushing's syndrome by liquid chromatography/tandem mass spectrometry assay.

Dana Erickson1, Ravinder J Singh, Airani Sathananthan, Adrian Vella, Sandra C Bryant.   

Abstract

BACKGROUND: Late-night salivary cortisol (LNSC) measurements have been increasingly used by physicians as an initial diagnostic test for evaluation of patients with clinical suspicion of Cushing's syndrome (CS). Published studies include various numbers of cases, controls and importantly, various assay methods (vast majority various immunoassays), as well as various methods to generate cut-points.
MATERIALS AND METHODS: The retrospective study evaluated the diagnostic utility of LNSC measurements in 249 patients evaluated for possibility of CS because of various clinical conditions using liquid chromatography/tandem mass spectrometry method (LC-MS/MS). CS was confirmed in 47 patients (18·9%) and excluded in 202 (81·1%) patients at the time of analysis.
RESULTS: Late-night salivary cortisol was abnormal or >2·8 nmol/l in 35 of 47 patients with CS; sensitivity of 74·5% and elevated in 20 of 202 patients who were found not to have CS; specificity 90·1%. Using receiver-operator characteristic statistics for calculation of the most optimal sensitivity and specificity, the cut-off based on this data was LNSC > 2·1 nmol/l with sensitivity of 83·0% and specificity of 84·2%.
CONCLUSION: Analysis of data at one referral institution showed somewhat limited sensitivity of LNSC for diagnosis of CS using current reference ranges.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21955126     DOI: 10.1111/j.1365-2265.2011.04239.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

1.  Practical evaluation of late-night salivary cortisol: a real-life approach.

Authors:  Zhanna E Belaya; Galina A Melnichenko
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

Review 2.  Update on late-night salivary cortisol for the diagnosis of Cushing's syndrome: methodological considerations.

Authors:  Hershel Raff
Journal:  Endocrine       Date:  2013-07-10       Impact factor: 3.633

3.  Urine free cortisol in the diagnosis of Cushing's syndrome: is it worth doing and, if so, how?

Authors:  Hershel Raff; Richard J Auchus; James W Findling; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2014-11-25       Impact factor: 5.958

Review 4.  The use of mass spectrometry to improve the diagnosis and the management of the HPA axis.

Authors:  Phillip J Monaghan; Brian G Keevil; Peter J Trainer
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

Review 5.  Cushing's Syndrome: Screening and Diagnosis.

Authors:  Filippo Ceccato; Marco Boscaro
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-05-09

6.  The diagnostic accuracy of increased late night salivary cortisol for Cushing's syndrome: a real-life prospective study.

Authors:  F Ceccato; G Marcelli; M Martino; C Concettoni; M Brugia; L Trementino; G Michetti; G Arnaldi
Journal:  J Endocrinol Invest       Date:  2018-07-09       Impact factor: 4.256

7.  Outpatient Randomized Crossover Automated Insulin Delivery Versus Conventional Therapy with Induced Stress Challenges.

Authors:  Ravinder Jeet Kaur; Sunil Deshpande; Jordan E Pinsker; Wesley P Gilliam; Shelly McCrady-Spitzer; Isabella Zaniletti; Donna Desjardins; Mei Mei Church; Francis J Doyle Iii; Walter K Kremers; Eyal Dassau; Yogish C Kudva
Journal:  Diabetes Technol Ther       Date:  2022-04-25       Impact factor: 7.337

8.  Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome.

Authors:  Joshua Kannankeril; Ty Carroll; James W Findling; Bradley Javorsky; Ian L Gunsolus; Jonathan Phillips; Hershel Raff
Journal:  J Endocr Soc       Date:  2020-07-24

Review 9.  Cortisol Measurements in Cushing's Syndrome: Immunoassay or Mass Spectrometry?

Authors:  Gregori Casals; Felicia Alexandra Hanzu
Journal:  Ann Lab Med       Date:  2020-07       Impact factor: 3.464

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.